1 |
Li, X., S. P. Raikwar, Y. H. Liu, S. J. Lee, Y. P. Zhang, S. Zahng, et al. 2006. Combination therapy of androgenindependent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene. Mol. Cancer Ther. 5: 676-684.
DOI
ScienceOn
|
2 |
Scorer, C. A., J. J. Clare, W. R. McCombie, M. A. Romano, and K. Sreekrishna. 1994. Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology 12: 181-184.
DOI
ScienceOn
|
3 |
Scappaticci, F. A., A. Ontreras, R. Smith, L. Bonhoure, B. Lum, Y. Cao, E. G. Engleman, and G. P. Nolan. 2001. Statin-AE: A novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activity. Angiogenesis 4: 263-268.
DOI
ScienceOn
|
4 |
Scappaticci, F. A., R. Smith, A. Pathak, D. Schloss, B. Lum, Y. Cao, F. Johnson, E. G. Engleman, and G. P. Nolan. 2001. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. Mol. Ther. 3: 186-196.
DOI
ScienceOn
|
5 |
Xiaoyan, M., L. Weibin, F. Shihong, L. Rende, and L. Guodong. 2006. Fusion expression and identification of angiostatin and endostatin in E. coli BL21(DE3). J. Biomed. Eng. 23: 1086- 1091
|
6 |
Su, Z., X. Wu, Y. Feng, C. Ding, Y. Xiao, L. Cai, W. Feng, and X. Li. 2007. High level expression of human endostatin in Pichia pastoris using a synthetic gene construct. Appl. Microbiol. Biotechnol. 73: 1355-1362.
DOI
ScienceOn
|
7 |
Tanaka, T., Y. Cao, J. Folkman, and H. A. Fine. 1998. Viral vectortargeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res. 58: 3362-3269.
|
8 |
Tysome, J. R., A. Briat, G. Alusi, F. Cao, D. Gao, J. Yu, et al. 2009. Lister strain of vaccinia virus armed with endostatinangiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer. Gene Ther. 16: 1223-1233.
DOI
ScienceOn
|
9 |
Yokoyama, Y., M. Dhababal, and A. W. Griffioen. 2000. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth. Cancer Res. 60: 2190-2196.
|
10 |
Zhang, A. L., T. Y. Zhang, J. X. Luo, S. C. Chen, W. J. Guan, C. Y. Fu, S. Q. Peng, and H. L. Li. 2007. Constitutive expression of human angiostatin in Pichia pastoris by highdensity cell culture. J. Ind. Microbiol. Biotechnol. 34: 117-122.
DOI
ScienceOn
|
11 |
Hajitou, A., C. Grignet-Debrus, L. Devy, S. Berndt, S. Blacher, C. F. Deroanne, et al. 2002. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J. 16: 1802-1804.
DOI
|
12 |
O'Reilly, M. S., L. Holmtren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, et al. 1994. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lesis Lung Carcinoma. Cell 79: 315-328.
DOI
ScienceOn
|
13 |
Li, X., S. P. Raikwar, Y. H. Liu, S. J. Lee, Y. P. Zhang, S. Zhang, et al. 2006. Combination therapy of androgenindependent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene. Mol. Cancer Ther. 5: 676-684.
DOI
ScienceOn
|
14 |
Li, X., Y. H. Liu, S. J. Lee, T. A. Gardner, M. H. Jeng, and C. Kao. 2008. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy. Clin. Cancer Res. 14: 291-299.
DOI
ScienceOn
|
15 |
Lin-Cereghino, G. P. and J. M. Cregg. 1999. Application of yeast in biotechnology: Protein production and genetic analysis. Curr. Opin. Biotechnol. 10: 422-427.
DOI
ScienceOn
|
16 |
O'Reilly, M. S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2: 689-692.
DOI
ScienceOn
|
17 |
O'Reilly, M. S., T. Boehm, Y. Shing, N. Fukai, G. Vasios, W. S. Lane, J. R. Birkhead, B. R. Olsen, and J. Folkman. 1997. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
DOI
ScienceOn
|
18 |
Pike, S. E., L. Yao, K. D. Jones, B. Cherney, E. Appella, K. Sakaguchi, et al. 1998. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 188: 2349-2356.
DOI
ScienceOn
|
19 |
Baneyx, F. 1999. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10: 411-421.
DOI
ScienceOn
|
20 |
Ambs, S., S. Dennis, J. Fairman, M. Wright, and J. Papkoff. 1999. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells. Cancer Res. 59: 5773-5777.
|
21 |
Cao, Y., M. S. O'Reilly, B. Marshall, E. Flynn, R. W. Ji, and J. Folkman. 1998. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101: 1055-1063.
DOI
ScienceOn
|
22 |
Carmeliet, P. and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
DOI
ScienceOn
|
23 |
Cregg, J. M., T. S. Vedvick, and W. V. Raschke. 1993. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology 11: 905-910.
DOI
ScienceOn
|
24 |
DiPietro, L. A. 1997. Thrombospondin as a regulator of angiogenesis. EXS 79: 295-314.
|
25 |
Folkman, J. 2000. Cancer Medicine. 5th Ed., pp. 132-152. BC Decker, Ontario, Canada.
|
26 |
Griscelli, F., H. Li, A. Bennaceur-Griscelli, J. Soria, P. Opolon, C. Soria, M. Perricaudet, P. Yeh, and H. Lu. 1998. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. U.S.A. 95: 6367-6372.
DOI
ScienceOn
|